豪悦护理(605009):2025Q3点评:收入环比提速,盈利略承压

Investment Rating - The investment rating for the company is "Buy" and is maintained [9]. Core Insights - In the first three quarters of 2025, the company achieved revenue of 2.718 billion yuan, net profit attributable to the parent company of 203 million yuan, and net profit excluding non-recurring items of 194 million yuan, representing year-on-year changes of +33%, -31%, and -33% respectively. In Q3 2025, the company reported revenue of 958 million yuan, net profit attributable to the parent company of 55 million yuan, and net profit excluding non-recurring items of 48 million yuan, with year-on-year changes of +32%, -45%, and -50% respectively [2][6]. Summary by Sections Revenue and Profitability - Q3 revenue grew by 32% year-on-year, showing a sequential acceleration compared to Q2. However, profitability faced pressure with a year-on-year decline in net profit margins [14]. - The gross margin in Q3 improved by 2.2 percentage points, primarily due to an increase in the proportion of self-owned brands. The sales, management, R&D, and financial expense ratios increased by 10.7, 0.1, -0.2, and 0.7 percentage points year-on-year, respectively [14]. Business Operations - The OEM business is gradually recovering, with orders from major clients starting to pick up. The self-owned brand, Dafy, is expected to continue its strong growth [14]. - The company is expanding its overseas production capacity in Peru and Tanzania, targeting emerging markets in Latin America and Africa, which is anticipated to open up new growth opportunities [14]. Market Position and Strategy - Despite the overall pressure in the infant diaper industry, the company is expected to increase its market share, with an estimated domestic market share of 9.3% in 2024, up from 4.2% in 2019. This growth is attributed to strong product capabilities and partnerships with leading brands [14]. - The company is focusing on enhancing its product offerings and optimizing channel operations for its brand, Jieting, which is expected to rejuvenate its market presence [14]. Financial Forecast - The projected net profit attributable to the parent company for 2025-2027 is 290 million, 380 million, and 460 million yuan, corresponding to price-to-earnings ratios of 24, 19, and 15 times [14].